{"id":16404,"date":"2023-08-10T20:11:00","date_gmt":"2023-08-10T20:11:00","guid":{"rendered":"https:\/\/agilusdiagnostics.com\/blogs\/covishield-covid-19-vaccine-efficacy-rate-cost-in-india\/"},"modified":"2026-02-23T09:39:28","modified_gmt":"2026-02-23T09:39:28","slug":"covishield-covid-19-vaccine-efficacy-rate-cost-in-india","status":"publish","type":"post","link":"https:\/\/agilusdiagnostics.com\/blogs\/covishield-covid-19-vaccine-efficacy-rate-cost-in-india\/","title":{"rendered":"COVISHIELD: COVID-19 Vaccine Efficacy Rate, Cost in India"},"content":{"rendered":"

About 300,000 people, mostly medical workers, were vaccinated in India on the first day of a nationwide coronavirus vaccination campaign launched on 16th of Jan 2021.<\/p>\n

On the first day of vaccination, about 100 volunteers in each of the 3006 vaccination sites in India completed vaccination. Manish Kumar became the first person to be vaccinated against COVID-19. Hence, we must know what exactly is Covishield and how effective it is? This article will provide you with information about the vaccine \u201cCovishield\u201d and the additional details you need to know about India\u2019s Covid-19 vaccines.<\/p>\n

What is COVISHIELD?<\/strong><\/h2>\n

Covishield vaccine made by<\/strong>\u00a0the University of Oxford and AstraZeneca is manufactured in India by the\u00a0Covishield vaccine company<\/strong>\u00a0Serum Institute of India (SII). The vaccine has been based on a weakened version of a\u00a0common cold<\/a><\/strong>\u00a0virus (adenovirus) that causes chimpanzees\u2019 infections.<\/p>\n

Oxford\u2019s Covishield corona vaccine trial started\u00a0<\/strong>in May and has completed three clinical trials.<\/p>\n

For the\u00a0Corona vaccine trial in India<\/strong>, a total of 3,006 vaccination centers are authorised, which will administer the\u00a0Covishield vaccine dose<\/strong>\u00a0to all public and private sector health workers initially.<\/p>\n

The authority has recommended administering two doses in an interval of 4-6 weeks. The Covishield vaccine will be stored at 2-8 degrees Celsius.<\/p>\n

Covishield efficacy rate<\/strong><\/h3>\n

Let us have a look at the possible\u00a0COVID vaccine success rate in India<\/strong>. Covishield has been tested in 4 countries with a demographically diverse population, ensuring that it is safe for use. According to data presented by the Serum Institute of India to authorities, the Drugs Controller General of India (DCGI) stated in a report that\u00a0Covishield vaccine success rate\u00a0<\/strong>in India is 70.42%. It is acceptable as most vaccine regulators approve > 50%\u00a0Covishield efficacy<\/strong>.<\/p>\n

Covishield vaccine side effects<\/strong><\/h3>\n

As a vaccine in general,\u00a0coronavirus<\/a>\u00a0vaccine side effects on health<\/strong>\u00a0after vaccination can be mild fever, pain and allergies, but it is generally safe.<\/p>\n

Covishield registration and communication<\/strong><\/h5>\n

To vaccinate 300 million people, India has also created a bold plan for communication and registration of people who will be immunised.<\/p>\n

The Indian government launched \u201cCo-WIN,\u201d a\u00a0coronavirus vaccine registration online<\/strong>\u00a0app that will send temperature information from all locations where vaccines will be stored to the New Delhi headquarters.<\/p>\n

The Co-WIN application\u2019s powerful and reliable technology will lay the foundation and backing for the national immunisation exercise. It will form the basis of last-mile vaccine management.<\/p>\n

The digital platform will also allow sending a message stating\u00a0register yourself for coronavirus vaccine<\/strong>, which will include the information of where and when you will receive the vaccine, also identifying which dose of the immunisation was administered during the vaccination. You can also find a\u00a0COVID-19 vaccine registration near you in India<\/strong>\u00a0through the government web portal.<\/p>\n

Also Read – How Long Does Immunity Last After COVID-19 Vaccination<\/a><\/strong><\/p>\n

Covishield distribution<\/strong><\/h3>\n

The Indian government has bought over 70 freezing chambers, 240 cold chambers, 45,000 ice-cooled refrigerators, 41,000 freezers, 300 solar-charge refrigerators and about 200,000 bathrooms for the vaccination drive especially for more precarious regions, such as close to indigenous communities or rural areas with electricity service problems exist and with the arrival of summer where temperatures in the country can go up to 40\u00b0C.<\/p>\n

For the huge vaccination work, approximately 150,000 employees in 700 regions have been specially trained. The central government has been working closely with all states, federal territories and stakeholders to carry out the vaccination activities.<\/p>\n

Covishield Vaccine Price<\/strong><\/h3>\n

The Serum Institute of India said\u00a0COVID-19 vaccine cost<\/strong>\u00a0starts in India at around Rs 400 per dose. However, there is no official news from the authorities on the\u00a0Covishield cost in India<\/strong>.<\/p>\n

India\u2019s Role Globally<\/strong><\/h3>\n

Globally, India provides more vaccines in quantity than any other country. It can also protect people in 91 other countries by providing more than 1 billion doses of drugs to the\u00a0 \u00a0Vaccine Alliance, Gavi COVAX AMC (Advanced Market Commitment).<\/p>\n

Agilus Diagnostics, a subsidiary of Fortis Healthcare Limited<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

On the first day of vaccination, about 100 volunteers in each of the 3006 vaccination sites in India completed vaccination. Manish Kumar became the first person to be vaccinated against COVID-19. Hence, we must know what exactly is Covishield and how effective it is? This article will provide you with information about the vaccine \u201cCovishield\u201d and the additional details you need to know about India\u2019s Covid-19 vaccines.<\/p>\n","protected":false},"author":1,"featured_media":17008,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[282],"tags":[284,330,331],"class_list":["post-16404","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-19","tag-covid19","tag-covishield","tag-vaccine"],"_links":{"self":[{"href":"https:\/\/agilusdiagnostics.com\/blogs\/wp-json\/wp\/v2\/posts\/16404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/agilusdiagnostics.com\/blogs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/agilusdiagnostics.com\/blogs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/agilusdiagnostics.com\/blogs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/agilusdiagnostics.com\/blogs\/wp-json\/wp\/v2\/comments?post=16404"}],"version-history":[{"count":2,"href":"https:\/\/agilusdiagnostics.com\/blogs\/wp-json\/wp\/v2\/posts\/16404\/revisions"}],"predecessor-version":[{"id":17654,"href":"https:\/\/agilusdiagnostics.com\/blogs\/wp-json\/wp\/v2\/posts\/16404\/revisions\/17654"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/agilusdiagnostics.com\/blogs\/wp-json\/wp\/v2\/media\/17008"}],"wp:attachment":[{"href":"https:\/\/agilusdiagnostics.com\/blogs\/wp-json\/wp\/v2\/media?parent=16404"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/agilusdiagnostics.com\/blogs\/wp-json\/wp\/v2\/categories?post=16404"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/agilusdiagnostics.com\/blogs\/wp-json\/wp\/v2\/tags?post=16404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}